Clinical Trials Browser

Testicular Germ Cell Tumor × 1 year × Clear all

Testicular Germ Cell Tumor, Breast Neoplasms, Ovarian Neoplasms, Sarcoma

NCT06276491 2026-03-17

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Testicular Germ Cell Tumor, Neoplasms, Germ Cell and Embryonal, Ovarian Neoplasms, Testicular Neoplasms, Endometrial Neoplasms

NCT07453082 2026-03-05

BRIDGE

Recruiting

100 enrolled

Genitourinary

Testicular Germ Cell Tumor

NCT05238883 2025-11-21

A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

Phase 1 Active not recruiting

72 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Melanoma, Mesothelioma, Sarcoma, Stomach Neoplasms

NCT03426865 2025-08-11

TESTPET

Completed

10 enrolled

Genitourinary

Testicular Germ Cell Tumor, Neoplasms, Germ Cell and Embryonal, Teratoma, Testicular Diseases, Testicular Neoplasms, Endodermal Sinus Tumor

NCT06940804 2025-07-02

AVENTURINE

Phase 2 Withdrawn

Genitourinary

Testicular Germ Cell Tumor, Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

Clinical Trials

HYPNO-AJA2

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

BRIDGE

A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

TESTPET

AVENTURINE